PROCYON CORP
Close on Oct 19, 2026
- Market cap
- $1.51M
- P/E (TTM)
- –
- Dividend yield
- –
About Procyon
Pharmaceutical Preparations, SIC 2834
Procyon Corporation, operating primarily through its wholly-owned subsidiary AMERX Health Care Corporation, develops and commercializes medical products for wound care and skin conditions. Its core offerings include advanced skin and wound care formulations under the AMERIGEL brand, HELIX3 bioactive collagen powders and pads, surgical collagen products under Advantagen, and EXTREMIT-EASE compression garments. The company also supplies dressing kits, retention tapes, and hand sanitizer. It serves institutional healthcare entities such as hospitals, wound clinics, skilled nursing facilities, and home health agencies, alongside healthcare practitioners. In addition, its products reach retail consumers through national chain drugstores, regional pharmacies, medical supply shops, and direct online channels.
The company conducts its operations from an 18,000-square-foot leased corporate office and warehouse facility situated in Oldsmar, Florida. Procyon employs 20 individuals, with nineteen working under AMERX and one under the parent entity. AMERX markets products primarily across the United States via institutional and retail distributors, while managing direct consumer sales online.
Summary of the business section of Procyon's latest annual report, written by StockData.
Company profile
Company
- Legal name
- PROCYON CORP
- Founded
- 1987
- Headquarters
- Clearwater, FL
- Address
- 1300 S Highland Ave 33756
- Phone
- (727) 447-2998
- Website
- amerxhc.com
- Employees
- 19, Jun 30, 2024
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Colorado
- Fiscal year ends
- June 30
- Auditor
- Ferlita, Walsh, Gonzalez & Rodriguez, P.A., Tampa, Florida
Stock & identifiers
- Ticker
- PCYN
- Exchange
- OTC
- IPO date
- Dec 30, 1998
- Shares outstanding
- 8M, Sep 28, 2024
- Public float
- $1.02M, Sep 24, 2024
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- SEC CIK
- 812306
- EIN
- 36-8732690
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Joseph Raymond Treshler | Director | 7,440 |
| Monica McCullough | Director | 7,200 |
| Steven McComas | Director | 5,600 |
| Fred Wilson Suggs Jr | Director | 125,000 |
Employees
Headcount reported in annual reports
“As of September 1, 2024, the Company and its subsidiary employ a total of 19 full time employees and 1 part time employee, consisting of 10 management employees, 3 sales-related employees and 7 administrative employees.”
Corporate history
Events identified from SEC filings